[HTML][HTML] Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: a consensus statement by the Society for …
Parametric mapping techniques provide a non-invasive tool for quantifying tissue alterations
in myocardial disease in those eligible for cardiovascular magnetic resonance (CMR) …
in myocardial disease in those eligible for cardiovascular magnetic resonance (CMR) …
[HTML][HTML] T1 mapping in cardiac MRI
D Radenkovic, S Weingärtner, L Ricketts, JC Moon… - Heart failure …, 2017 - Springer
Quantitative myocardial and blood T 1 have recently achieved clinical utility in numerous
pathologies, as they provide non-invasive tissue characterization with the potential to …
pathologies, as they provide non-invasive tissue characterization with the potential to …
Clinical impact of cardiac MRI T1 and T2 parametric mapping in patients with suspected cardiomyopathy
W Warnica, A Al-Arnawoot, A Stanimirovic… - Radiology, 2022 - pubs.rsna.org
Background There are limited data on the incremental value of parametric mapping
compared with core cardiac MRI protocols for suspected cardiomyopathy in routine clinical …
compared with core cardiac MRI protocols for suspected cardiomyopathy in routine clinical …
Cardiac T2* mapping: Techniques and clinical applications
P Triadyaksa, M Oudkerk… - Journal of Magnetic …, 2020 - Wiley Online Library
Cardiac T2* mapping is a noninvasive MRI method that is used to identify myocardial iron
accumulation in several iron storage diseases such as hereditary hemochromatosis, sickle …
accumulation in several iron storage diseases such as hereditary hemochromatosis, sickle …
Association between diffuse myocardial fibrosis and diastolic dysfunction in sickle cell anemia
Sickle cell anemia (SCA)–related cardiomyopathy is characterized by diastolic dysfunction
and hyperdynamic features. Diastolic dysfunction portends early mortality in SCA. Diastolic …
and hyperdynamic features. Diastolic dysfunction portends early mortality in SCA. Diastolic …
Use of myocardial T1 mapping at 3.0 T to differentiate Anderson-Fabry disease from hypertrophic cardiomyopathy
GR Karur, S Robison, RM Iwanochko, CF Morel… - Radiology, 2018 - pubs.rsna.org
Purpose To compare left ventricular (LV) and right ventricular (RV) 3.0-T cardiac magnetic
resonance (MR) imaging T1 values in Anderson-Fabry disease (AFD) and hypertrophic …
resonance (MR) imaging T1 values in Anderson-Fabry disease (AFD) and hypertrophic …
T1 and T2 mapping in cardiology:“mapping the obscure object of desire”
S Mavrogeni, D Apostolou, P Argyriou, S Velitsista… - Cardiology, 2017 - karger.com
The increasing use of cardiovascular magnetic resonance (CMR) is based on its capability
to perform biventricular function assessment and tissue characterization without radiation …
to perform biventricular function assessment and tissue characterization without radiation …
[HTML][HTML] Myocardial iron overload by cardiovascular magnetic resonance native segmental T1 mapping: a sensitive approach that correlates with cardiac …
Background We compared cardiovascular magnetic resonance segmental native T1 against
T2* values for the detection of myocardial iron overload (MIO) in thalassaemia major and we …
T2* values for the detection of myocardial iron overload (MIO) in thalassaemia major and we …
[HTML][HTML] Cardiovascular magnetic resonance (CMR) in restrictive cardiomyopathies
The restrictive cardiomyopathies constitute a heterogeneous group of myocardial diseases
with a different pathogenesis and overlapping clinical presentations. Diagnosing them …
with a different pathogenesis and overlapping clinical presentations. Diagnosing them …
[HTML][HTML] Cardiovascular magnetic resonance native T2 and T2* quantitative values for cardiomyopathies and heart transplantations: a systematic review and meta …
GJH Snel, M van den Boomen, LM Hernandez… - Journal of …, 2020 - Elsevier
Background The clinical application of cardiovascular magnetic resonance (CMR) T 2 and T
2* mapping is currently limited as ranges for healthy and cardiac diseases are poorly …
2* mapping is currently limited as ranges for healthy and cardiac diseases are poorly …